Colonoscopy preparation adequacy in glucagon-like peptide-1 receptor agonist users: the jury is still out

• References

• 1 Joseph DA, Meester RG, Zauber AG. et al. Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacity. Cancer 2016; 122: 2479-2486
• 2 Kaminski MF, Thomas-Gibson S, Bugajski M. et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J 2017; 5: 309-334
• 3 Rex DK, Anderson JC, Butterly LF. et al. Quality indicators for colonoscopy. Am J Gastroenterol 2024;
• 4 Gratzl S, Rodriguez PJ, Goodwin BM. et al. Monitoring report: GLP-1 RA prescribing monitoring report: GLP-1 RA prescribing trends - June 2024 Data. Accessed October 24, 2024 at: https://www.medrxiv.org/content/10.1101/2024.01.18.24301500v3
• 5 Facciorusso A, Ramai D, Dhar J. et al. Effects of glucagon-like peptide-1 receptor agonists on upper gastrointestinal endoscopy: a meta-analysis. Clin Gastroenterol Hepatol 2024;
• 6 Abu-Freha N, Yitzhak A, Shirin H. et al. Glucagon-like peptide-1 receptor agonists significantly affect the quality of bowel preparation for colonoscopy. Endoscopy 2024;
• 7 Yao R, Gala KS, Ghusn W. et al. Effect of glucagon-like peptide-1 receptor agonists on bowel preparation for colonoscopy. Am J Gastroenterol 2024; 119: 1154-1157
• 8 Tong Y, Huang JQ, Chen Y. et al. Impact of glucagon-like peptide 1 receptor agonist liraglutide and dipeptidyl peptidase-4 inhibitor sitagliptin on bowel cleaning and gastrointestinal symptoms in type 2 diabetes. Front Pharmacol 2023; 14: 1176206
• 9 Sharma T, Das N, Ismail B. et al. Evaluation of the effect of GLP-1 agonists on quality of bowel preparation for colonoscopy in patients with diabetes. Pract Diabetes 2017; 34: 167-168